2024 annual financial data
ImmunityBio, Inc. 2024 Operating margin
ImmunityBio, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was -2,334.23%.
Operating income was -344,182,000 USD and net income was -413,564,000 USD.
Operating cash flow was -391,236,000 USD.
Get free ImmunityBio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,745,000 USD
- Operating income
- -344,182,000 USD
- Net income
- -413,564,000 USD
- Operating cash flow
- -391,236,000 USD